{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T08:02:22Z","timestamp":1780646542460,"version":"3.54.1"},"reference-count":28,"publisher":"IOP Publishing","issue":"3","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/publishingsupport.iopscience.iop.org\/iop-standard\/v1"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":4,"URL":"https:\/\/iopscience.iop.org\/info\/page\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/publishingsupport.iopscience.iop.org\/questions\/alternative-author-rights-policies\/"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/publishingsupport.iopscience.iop.org\/questions\/alternative-author-rights-policies\/"}],"content-domain":{"domain":["iopscience.iop.org"],"crossmark-restriction":false},"short-container-title":["Biomed. Mater."],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Three-dimensional (3D) culture more faithfully reproduces\n                    <jats:italic>in vivo<\/jats:italic>\n                    \u2013like cell interactions and functions than conventional two-dimensional (2D) monolayers. Although HepG2 cells are widely used in drug discovery, their 2D cultures exhibit low expression of drug-metabolizing enzymes such as cytochrome P450s (CYPs), limiting utility for toxicity and pharmacokinetic studies. Nano-fibrillated bacterial cellulose (NFBC) is a unique biomaterial that features exceptional homogeneity, high purity, and excellent biocompatibility. We recently employed two NFBC-based 3D culture systems: the Suspension and the OnGel methods. However, the capacity of NFBC to improve hepatocyte-specific functions has yet to be systematically explored. In this study, we aimed to establish a 3D culture platform for HepG2 cells using NFBC to restore hepatic functionality, and drug-metabolizing activity in particular, via comparison with conventional 2D monolayers. Both of these 3D culture systems produced viable HepG2 spheroids with good proliferation. Exploratory microarray profiling suggested broad upregulation of multiple absorption, distribution, metabolism and excretion (ADME) genes in the HepG2 spheroids. Among these, the enzyme Cytochrome P450 3A4 (CYP3A4) showed a significant increase in protein expression and in enzymatic activity in the HepG2 spheroids, which was functionally confirmed by acetaminophen (APAP) toxicity via its bioactivation into toxic metabolite. In addition, the HepG2 spheroids displayed reduced sensitivity to the anticancer drug doxorubicin compared to 2D monolayer. Collectively, these findings demonstrate that NFBC-based 3D culture systems effectively restore liver-specific functions in HepG2 cells, which results in HepG2 spheroids with metabolic competence and physiologically relevant drug responses, and could offer a promising tool for high-throughput\n                    <jats:italic>in vitro<\/jats:italic>\n                    drug screening.\n                  <\/jats:p>","DOI":"10.1088\/1748-605x\/ae7243","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T07:16:41Z","timestamp":1780643801000},"page":"035025","update-policy":"https:\/\/doi.org\/10.1088\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Three-dimensional cell-culture systems using nanofibrillated bacterial cellulose restores drug metabolism activity in HepG2 hepatocellular carcinoma cells"],"prefix":"10.1088","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6247-7574","authenticated-orcid":true,"given":"Hidenori","family":"Ando","sequence":"first","affiliation":[{"name":"Institute of Biomedical Sciences, Tokushima University"},{"name":"Institute of Biomedical Sciences, Tokushima University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8683-6844","authenticated-orcid":true,"given":"Cristina Nana","family":"Amorim Matsuo","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Sciences, Tokushima University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Akagi","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Sciences, Tokushima University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3238-813X","authenticated-orcid":true,"given":"Kenji","family":"Tajima","sequence":"additional","affiliation":[{"name":"Hokkaido University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Takata","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Sciences, Tokushima University"},{"name":"Institute of Biomedical Sciences, Tokushima University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Serizawa","sequence":"additional","affiliation":[{"name":"Kusano Sakko Inc."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tokuo","family":"Matsushima","sequence":"additional","affiliation":[{"name":"Kusano Sakko Inc."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takatomo","family":"Kusano","sequence":"additional","affiliation":[{"name":"Kusano Sakko Inc."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuhiro","family":"Ishida","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Sciences, Tokushima University"},{"name":"Institute of Biomedical Sciences, Tokushima University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"266","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"bmmae7243bib1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1089\/adt.2014.573","type":"journal-article","article-title":"Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors","volume":"12","author":"Edmondson","year":"2014","journal-title":"Assay Drug Dev. Technol."},{"key":"bmmae7243bib2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/jcp.24683","type":"journal-article","article-title":"3D cell culture systems: advantages and applications","volume":"230","author":"Ravi","year":"2015","journal-title":"J. Cell Physiol."},{"key":"bmmae7243bib3","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s00204-013-1078-5","type":"journal-article","article-title":"Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME","volume":"87","author":"Godoy","year":"2013","journal-title":"Arch. Toxicol."},{"key":"bmmae7243bib4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10565-011-9208-4","type":"journal-article","article-title":"Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins","volume":"28","author":"Gerets","year":"2012","journal-title":"Cell Biol. Toxicol."},{"key":"bmmae7243bib5","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1124\/dmd.107.020016","type":"journal-article","article-title":"Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies","volume":"36","author":"Kanebratt","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"bmmae7243bib6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1021\/bp00015a007","type":"journal-article","article-title":"A stable long-term hepatocyte culture system for studies of physiologic processes: cytokine stimulation of the acute phase response in rat and human hepatocytes","volume":"8","author":"Bader","year":"1992","journal-title":"Biotechnol. Prog."},{"key":"bmmae7243bib7","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1002\/hep.24132","type":"journal-article","article-title":"HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicity","volume":"53","author":"McGill","year":"2011","journal-title":"Hepatology"},{"key":"bmmae7243bib8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cbi.2006.12.003","type":"journal-article","article-title":"The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics","volume":"168","author":"Guillouzo","year":"2007","journal-title":"Chem. Biol. Interact."},{"key":"bmmae7243bib9","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1124\/dmd.31.8.1035","type":"journal-article","article-title":"Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties","volume":"31","author":"Wilkening","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"bmmae7243bib10","doi-asserted-by":"publisher","DOI":"10.1038\/srep25187","type":"journal-article","article-title":"Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease","volume":"6","author":"Bell","year":"2016","journal-title":"Sci. Rep."},{"key":"bmmae7243bib11","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1016\/j.biomaterials.2011.12.006","type":"journal-article","article-title":"Tethered spheroids as an in vitro hepatocyte model for drug safety screening","volume":"33","author":"Xia","year":"2012","journal-title":"Biomaterials"},{"key":"bmmae7243bib12","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1007\/s11095-013-1007-6","type":"journal-article","article-title":"Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis","volume":"30","author":"McGill","year":"2013","journal-title":"Pharm. Res."},{"key":"bmmae7243bib13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12885-017-3953-6","type":"journal-article","article-title":"Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins","volume":"18","author":"Lovitt","year":"2018","journal-title":"BMC Cancer"},{"key":"bmmae7243bib14","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1007\/s10570-013-0050-0","type":"journal-article","article-title":"One-step production of nanofibrillated bacterial cellulose (NFBC) from waste glycerol using Gluconacetobacter intermedius NEDO-01","volume":"20","author":"Kose","year":"2013","journal-title":"Cellulose"},{"key":"bmmae7243bib15","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1021\/acs.biomac.7b01100","type":"journal-article","article-title":"One-step production of amphiphilic nanofibrillated cellulose using a cellulose-producing bacterium","volume":"18","author":"Tajima","year":"2017","journal-title":"Biomacromolecules"},{"key":"bmmae7243bib16","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpta.2024.100565","type":"journal-article","article-title":"Detailed structural analyses and viscoelastic properties of nano-fibrillated bacterial celluloses","volume":"8","author":"Tsujisaki","year":"2024","journal-title":"Carbohydrate Polym. Technol. Appl."},{"key":"bmmae7243bib17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.142658","type":"journal-article","article-title":"Morphological details of cellulose nanofibers and their composites for Raman sensing application","volume":"310","author":"Ree","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"bmmae7243bib18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1248\/bpb.b24-00804","type":"journal-article","article-title":"A 3D cell-culture system that uses nano-fibrillated bacterial cellulose to prepare a spherical formulation of culture cells","volume":"48","author":"Akagi","year":"2025","journal-title":"Biol. Pharm. Bull."},{"key":"bmmae7243bib19","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/j.biomaterials.2012.11.029","type":"journal-article","article-title":"3D spheroid culture of hESC\/hiPSC-derived hepatocyte-like cells for drug toxicity testing","volume":"34","author":"Takayama","year":"2013","journal-title":"Biomaterials"},{"key":"bmmae7243bib20","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1517\/17425250903160664","type":"journal-article","article-title":"Liver tissue engineering in the evaluation of drug safety","volume":"5","author":"Dash","year":"2009","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"bmmae7243bib21","doi-asserted-by":"publisher","first-page":"F1","DOI":"10.1152\/ajprenal.00373.2015","type":"journal-article","article-title":"Discerning the role of mechanosensors in regulating proximal tubule function","volume":"310","author":"Raghavan","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"bmmae7243bib22","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1089\/ten.tea.2009.0668","type":"journal-article","article-title":"Tissue-engineered three-dimensional tumor models to study tumor angiogenesis","volume":"16","author":"Verbridge","year":"2010","journal-title":"Tissue Eng. A"},{"key":"bmmae7243bib23","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jcmgh.2017.11.012","type":"journal-article","article-title":"Bioengineered liver models for drug testing and cell differentiation studies","volume":"5","author":"Underhill","year":"2018","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"bmmae7243bib24","doi-asserted-by":"publisher","first-page":"629","DOI":"10.2174\/138920006778017759","type":"journal-article","article-title":"Molecular mechanisms underlying the dedifferentiation process of isolated hepatocytes and their cultures","volume":"7","author":"Elaut","year":"2006","journal-title":"Curr. Drug Metab."},{"key":"bmmae7243bib25","doi-asserted-by":"publisher","first-page":"30650","DOI":"10.1074\/jbc.M806132200","type":"journal-article","article-title":"Cyclin-dependent kinase 2 negatively regulates human pregnane X receptor-mediated CYP3A4 gene expression in HepG2 liver carcinoma cells","volume":"283","author":"Lin","year":"2008","journal-title":"J. Biol. Chem."},{"key":"bmmae7243bib26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jbiotec.2010.01.012","type":"journal-article","article-title":"Multicellular tumor spheroids: an underestimated tool is catching up again","volume":"148","author":"Hirschhaeuser","year":"2010","journal-title":"J. Biotechnol."},{"key":"bmmae7243bib27","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3892\/ijmm.12.5.693","type":"journal-article","article-title":"E-cadherin-dependent intercellular adhesion enhances chemoresistance","volume":"12","author":"Nakamura","year":"2003","journal-title":"Int. J. Mol. Med."},{"key":"bmmae7243bib28","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-020-00638-x","type":"journal-article","article-title":"A novel c-Kit\/phospho-prohibitin axis enhances ovarian cancer stemness and chemoresistance via Notch3-PBX1 and beta-catenin-ABCG2 signaling","volume":"27","author":"Fang","year":"2020","journal-title":"J. Biomed. Sci."}],"container-title":["Biomedical Materials"],"original-title":[],"link":[{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/ae7243","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/ae7243\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/ae7243\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/ae7243\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T07:16:42Z","timestamp":1780643802000},"score":1,"resource":{"primary":{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/ae7243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6,5]]},"published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1088\/1748-605x\/ae7243","relation":{},"ISSN":["1748-6041","1748-605X"],"issn-type":[{"value":"1748-6041","type":"print"},{"value":"1748-605X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"Three-dimensional cell-culture systems using nanofibrillated bacterial cellulose restores drug metabolism activity in HepG2 hepatocellular carcinoma cells","name":"article_title","label":"Article Title"},{"value":"Biomedical Materials","name":"journal_title","label":"Journal Title"},{"value":"paper","name":"article_type","label":"Article Type"},{"value":"\u00a9 2026 IOP Publishing Ltd. All rights, including for text and data mining, AI training, and similar technologies, are reserved.","name":"copyright_information","label":"Copyright Information"},{"value":"2025-12-11","name":"date_received","label":"Date Received","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2026-05-22","name":"date_accepted","label":"Date Accepted","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2026-06-05","name":"date_epub","label":"Online publication date","group":{"name":"publication_dates","label":"Publication dates"}}]}}